Loading...
GnRHa/Stanozolol Combined Therapy Maintains Normal Bone Growth in Central Precocious Puberty
BACKGROUND: Gonadotropin-releasing hormone agonist (GnRHa) is the gold standard in the treatment of Central Precocious Puberty (CPP) with progressive puberty and accelerative growth. However, GnRHa treatment is reported to result in growth deceleration and prevents growth plate development which lea...
Na minha lista:
| Udgivet i: | Front Endocrinol (Lausanne) |
|---|---|
| Main Authors: | , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Frontiers Media S.A.
2021
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8221533/ https://ncbi.nlm.nih.gov/pubmed/34177807 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fendo.2021.678797 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|